Revance Therapeutics Announces Proposed Public Offering of Common Stock

By: via Benzinga
Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced a proposed underwritten public offering of 3,250,000shares of its common ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.